Apyx Medical
APYX
39 hedge funds and large institutions have $19.5M invested in Apyx Medical in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 8 closing their positions.
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
5% more funds holding
Funds holding: 37 → 39 (+2)
1% more capital invested
Capital invested by funds: $19.3M → $19.5M (+$161K)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HK
Horizon Kinetics
New York
|
+$1.51M |
| 2 |
CPA
Cowen Prime Advisors
New York
|
+$413K |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$198K |
| 4 |
Millennium Management
New York
|
+$60.4K |
| 5 |
Renaissance Technologies
New York
|
+$44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$322K |
| 2 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$197K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$97.4K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$75K |
| 5 |
Bank of New York Mellon
New York
|
-$35K |
APYX Hedge Fund Activity: Q2 2017 in Review
39 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q2 2017, worth a combined $19.5M — up 0.83% from $19.3M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new APYX positions and 8 closed out — a net gain of 2 holders — while 9 added to existing stakes and 10 trimmed.
The largest buyer was Horizon Kinetics, opening a new position worth an estimated $1.51M. The largest seller was Great Point Partners, cutting an estimated $322K.
- 39 institutional investors held Apyx Medical (APYX) as of Q2 2017, up from 37 in Q1 2017.
- Funds reported $19.5M of Apyx Medical stock for Q2 2017, up 0.83% quarter-over-quarter.
- 10 funds opened new Apyx Medical positions in Q2 2017 and 8 closed out, a net change of +2 holders.
- The largest Apyx Medical buyer in Q2 2017 was Horizon Kinetics, an estimated $1.51M added.
- The largest Apyx Medical seller in Q2 2017 was Great Point Partners, an estimated $322K sold.
Based on aggregated 13F filings for Q2 2017.